Siomycin A

Siomycin A

12656-09-6

C₇₁H₈₁ N₁₉ O₁₈ S₅

CC=C1C2=NC(CS2)C(=O)NC(C3=NC(=CS3)C(=O)NC4C(OC(=O)C5=NC6=C(C=CC(C6O)NC(C(=O)NC(=C)C(=O)NC(=C)C(=O)NC(C(=O)NC7(CCC(=NC7C8=CSC4=N8)C9=NC(=CS9)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)C2=NC(=CS2)C(=O)NC(C(=O)N1)C(C)O)C)C(C)C)C(=C5)C(C)O)C)C(C)(C(C)O)O

4)-lactone, (4® ; mutabilycin, sporangiomycin, 6741-21, mutabillicin ; mutabillicin ; siomycin a ; alaninamide,l-threonyl-(4s)-2-[(1z)-1-amino-1-propenyl]-4,5-dihydro-4-thiazolecarbonyl-2-[(1s,2s,3r)-1-amino-2,3-dihydroxy-2-methylbutyl]-4-thiazolecarbonyl-2-[(5r,6s)-6-[2-[(1s,2r)-1-amino-2-hydroxypropyl]-4-thiazolyl]-5-[[n-[(7r,8s)-2-carboxy-7,8-dihydro-8-hydroxy-4-[(1s)-1-hydroxyethyl]-7-quinolinyl]-l-valyl-2,3-didehydroalanyl-2,3-didehydroalanyl-l-alanyl]amino]-5-(4-carboxy-2-thiazolyl)-3,4,5,6-tetrahydro-2-pyridinyl]-4-thiazolecarbonyl-2,3-didehydroalanyl-2,3-didehydro-,(1'® ; nsc 285116 ; mutabilycin ; alaninamide,n-[(7r,8s)-2-carboxy-7,8-dihydro-8-hydroxy-4-[(1s)-1-hydroxyethyl]-7-quinolinyl]-l-valyl-2,3-didehydroalanyl-2,3-didehydroalanyl-l-alanyl-2-[(4ar,11s,14z,18s,21s,28s,32as)-4a-amino-21-[(1s,2r)-1,2-dihydroxy-1-methylpropyl]-14-ethylidene-3,4,4a,9,10,11,12,13,14,18,19,20,21,27,28,32a-hexadecahydro-11,28-bis[(1r)-1-hydroxyethyl]-9,12,19,26-tetraoxo-17h,26h-8,5:18,15:25,22:32,29-tetranitrilo-5h,15h-pyrido[3,2-m][1,11,17,24,4,7,20,27]tetrathiatetraazacyclotriacontin-2-yl]-4-thiazolecarbonyl-2,3-dideh ; 1)-lactam (9ci) ; 17h,26h-4a,28-(iminoethaniminoethaniminoethaniminoethanimino[7,2]quinolinomethanoxymethano)-8,5:18,15:25,22:32,29-tetranitrilo-4h,15h-pyrido[3,2-m][1,11,17,24,4,7,20,27]tetrathiatetraazacyclotriacontine,cyclic peptide deriv. ; antibiotic 6741-21